LEXINGTON, Mass., March 6, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Roth 24th Annual OC Growth Stock Conference at 11:30 a.m. PT on March 13, 2012, in Laguna Niguel, CA.
